Matteo Levisetti SEC EDGAR Filings (CIK 0001962444)

SEC EDGAR filings, ownership reports, and insider transactions for Matteo Levisetti.

Business address
C/O Cue Biopharma, Inc., 40 Guest Street, Boston, MA, 02135
Get insider transactions for this reporting owner
Matteo Levisetti has filed 8 SEC EDGAR filings since 19 Jan 2023

Latest Filings

Recent SEC filings for Matteo Levisetti including 144, 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
144 Open 144 document View SEC filing for 144 29 Dec 2025
4 Open 4 document View SEC filing for 4 4 25 Mar 2025 21 Mar 2025 001-38327
4 Open 4 document View SEC filing for 4 4 07 Jun 2024 05 Jun 2024 001-38327
4 Open 4 document View SEC filing for 4 4 08 Mar 2024 06 Mar 2024 001-38327
4 Open 4 document View SEC filing for 4 4 22 Feb 2024 20 Feb 2024 001-38327
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 25 Jul 2023 21 Jul 2023 001-38327
4 Open 4 document View SEC filing for 4 FORM 4 SUBMISSION 19 Jan 2023 17 Jan 2023 001-38327
3 Open 3 document View SEC filing for 3 FORM 3 SUBMISSION 19 Jan 2023 17 Jan 2023 001-38327

About this filer

Matteo Levisetti files with the SEC under CIK 0001962444. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages